Literature DB >> 1732954

Popliteal and tibioperoneal arteries: feasibility of two-dimensional time-of-flight MR angiography and phase velocity mapping.

G R Caputo1, T Masui, G A Gooding, J M Chang, C B Higgins.   

Abstract

To assess the feasibility of using magnetic resonance (MR) angiography and velocity-encoded cine MR imaging to evaluate morphology and function in the popliteal and tibioperoneal arteries, the profiles of blood flow velocity measured with velocity-encoded cine MR were compared with those measured with color-coded sonography. Two-dimensional time-of-flight MR angiography was performed in the popliteal and tibioperoneal arteries of 10 healthy subjects; velocity-encoded cine MR and color-coded sonography were performed above and below the trifurcation. The velocity waveforms acquired with velocity-encoded cine MR and color-coded sonography correlated well and showed a typical triphasic pattern. At peak systole in the popliteal artery, spatial maximum and spatial mean velocities measured with velocity-encoded cine MR were 42.29 cm/sec +/- 9.55 (standard deviation) and 27.7 cm/sec +/- 5.8, respectively; the peak velocity measured with color-coded sonography was 44.2 cm/sec +/- 12.3. It is concluded that use of both MR angiography and velocity-encoded cine MR should be considered for identification of arterial stenoses and assessment of the hemodynamic importance of peripheral vascular stenoses.

Entities:  

Mesh:

Year:  1992        PMID: 1732954     DOI: 10.1148/radiology.182.2.1732954

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

Review 1.  Magnetic resonance imaging and measurement of blood flow.

Authors:  C H McDonnell; R J Herfkens; A M Norbash; G D Rubin
Journal:  West J Med       Date:  1994-03

2.  Magnetic resonance angiography of intravascular endoprostheses: investigation of three devices.

Authors:  J P Laissy; C Grand; C Matos; J Struyven; J F Berger; E Schouman-Claeys
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.